Lan Yang

2.1k citations
57 papers · 1.6k · 1 hit paper · h-index 20

Impact in

    • MicroRNA in disease regulation
    • Cancer-related molecular mechanisms research
    • Circular RNAs in diseases
    • RNA modifications and cancer
    • Epigenetics and DNA Methylation
    • RNA Research and Splicing

Papers in

    • RNA modifications and cancer 10
    • Cancer-related gene regulation 7
    • Epigenetics and DNA Methylation 7
    • Circular RNAs in diseases 5
    • Cancer-related molecular mechanisms research 9
    • MicroRNA in disease regulation 8

Lan Yang

52 papers receiving 1.5k citations

Hit Papers

Epigenetically upregulated oncoprotein PLCE1 drives esophageal carcinoma angiogenesis and proliferation via activating the PI-PLCε-NF-κB signaling pathway and VEGF-C/ Bcl-2 expression 2019 · 306 citations
3060+2+4Years since publication100200300

Peers

Lan Yang
Comparison fields: 5 of 110
  • Cancer Research 435
  • Molecular Biology 1.0k
  • Genetics 319
  • Immunology 230
  • Oncology 270
Replace Roxana Schillaci with:
Roxana Schillaci Argentina
Chun A. Changou Taiwan
Yan Jin China
Brian M. Necela United States
Weiwei Li China
Lan Kang China
Ming Yu United States
Jaideep Chaudhary United States
Dinglan Wu China
Lan Yang relative to Roxana Schillaci Argentina Roxana Schillaci's profile →
Citations per field
00.5×1.5×
Roxana Schillaci · 1×
Citations per year

Countries citing papers authored by Lan Yang

Since Specialization
Citations

This map shows the geographic impact of Lan Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lan Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lan Yang more than expected).

Fields of papers citing papers by Lan Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lan Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lan Yang. The network helps show where Lan Yang may publish in the future.

Co-authors

The 25 scholars most cited alongside Lan Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lan Yang Line = papers co-authored together Lan Yang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Epigenetically upregulated oncoprotein PLCE1 drives esophageal carcinoma angiogenesis and proliferation via activating the PI-PLCε-NF-κB signaling pathway and VEGF-C/ Bcl-2 expression
Hit paper breakdown →
2019306
2 1999255
3 2000113
4 201571
5 199970
6 201565
7 201757
8 201751
9 201949
10 201944
11 201340
12 201034
13 201326
14 200423
15 200923
16 201421
17 201721
18 201920
19
Bcl-xL overexpression and its association with the progress of tongue carcinoma.
201420
20 201519

About Lan Yang

Lan Yang is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Surgery, having authored 57 papers that have together received 1.6k indexed citations. Recurring topics across this work include RNA modifications and cancer (10 papers), Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (8 papers), Cancer-related gene regulation (7 papers), Epigenetics and DNA Methylation (7 papers), Circular RNAs in diseases (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Esophageal Cancer Research and Treatment (4 papers). The work is most often cited by research in Cancer Research (435 citations), Molecular Biology (1.0k citations), Genetics (319 citations), Immunology (230 citations) and Oncology (270 citations). Lan Yang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Michael R. Stallcup, Heng Hong, Jianming Hu, Xiaobin Cui, Yunzhao Chen, Donald Defranco, Hao Peng, Hong Zhou, Dandan Wang and Jun Li. Their work appears in journals such as Journal of Biological Chemistry, Advances in experimental medicine and biology, Journal of Experimental & Clinical Cancer Research, Epigenetics and Journal of Cellular Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact